PRME vs. CRBP
Compare and contrast key facts about Prime Medicine Inc. Common Stock (PRME) and Corbus Pharmaceuticals Holdings, Inc. (CRBP).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PRME or CRBP.
Correlation
The correlation between PRME and CRBP is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
PRME vs. CRBP - Performance Comparison
Key characteristics
PRME:
-0.75
CRBP:
-0.60
PRME:
-1.10
CRBP:
-0.38
PRME:
0.88
CRBP:
0.94
PRME:
-0.71
CRBP:
-0.66
PRME:
-1.22
CRBP:
-1.29
PRME:
51.76%
CRBP:
49.65%
PRME:
84.09%
CRBP:
106.41%
PRME:
-89.20%
CRBP:
-99.31%
PRME:
-85.18%
CRBP:
-97.33%
Fundamentals
PRME:
$430.86M
CRBP:
$95.00M
PRME:
-$2.06
CRBP:
-$4.71
PRME:
$38.57M
CRBP:
$0.00
PRME:
$37.26M
CRBP:
-$351.69K
PRME:
-$153.83M
CRBP:
-$31.87M
Returns By Period
In the year-to-date period, PRME achieves a 7.19% return, which is significantly higher than CRBP's -29.83% return.
PRME
7.19%
7.56%
-24.40%
-63.13%
N/A
N/A
CRBP
-29.83%
-30.60%
-86.09%
-69.50%
-45.12%
-18.67%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
PRME vs. CRBP — Risk-Adjusted Performance Rank
PRME
CRBP
PRME vs. CRBP - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Prime Medicine Inc. Common Stock (PRME) and Corbus Pharmaceuticals Holdings, Inc. (CRBP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PRME vs. CRBP - Dividend Comparison
Neither PRME nor CRBP has paid dividends to shareholders.
Drawdowns
PRME vs. CRBP - Drawdown Comparison
The maximum PRME drawdown since its inception was -89.20%, smaller than the maximum CRBP drawdown of -99.31%. Use the drawdown chart below to compare losses from any high point for PRME and CRBP. For additional features, visit the drawdowns tool.
Volatility
PRME vs. CRBP - Volatility Comparison
The current volatility for Prime Medicine Inc. Common Stock (PRME) is 26.13%, while Corbus Pharmaceuticals Holdings, Inc. (CRBP) has a volatility of 29.16%. This indicates that PRME experiences smaller price fluctuations and is considered to be less risky than CRBP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
PRME vs. CRBP - Financials Comparison
This section allows you to compare key financial metrics between Prime Medicine Inc. Common Stock and Corbus Pharmaceuticals Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities